H2Bub1 is a well-known key target of USP22 in cancer cells, and it is involved in histone modification and gene expression; loss of H2Bub1 is frequently observed in and associated with more malignant phenotype and poor prognosis of various cancers [49–51]. This evidence concerns the gene USP22 and cancer.